Table 3. The peptide fragments resulting from in silico GI digestion along with their respective reported bioactive properties

Peptide sequence	Peptide fragment after in silico GI digestion	Bioactivity of the fragments (BIOPEP database)	Bioactivity of the fragments (DFBP database)
IAWGK	IAGK	(IA) ACE inhibitor, DPP-IV inhibitor(GK) ACE inhibitor	(IA) Antioxidant(GK) Antioxidant
VDLL	VD	(VD) DPP-IV inhibitor	(VD) Antioxidant
MTTPNK	Intact	-	-
MPLVR	MPLVR	(MP) DPP-IV inhibitor(LVR) ACE inhibitor	(MP) Antioxidant(LVR) Antioxidant
KIII	Intact	-	-
LPQL	PQL	-	(PQL) ACE inhibitor, Antioxidant
TVIL	TVI	-	-
DFPGLQ	DFPGL	(DF) ACE inhibitor(PGL) ACE inhibitor	(DF) Antioxidant(PGL) Antioxidant
VEDVK	Intact	-	-

GI, gastrointestinal; ACE, angiotensin-converting enzyme; DPP-IV, dipeptidyl peptidase-IV.